Ambea AB (publ) (LON:0RNX)
London · Delayed Price · Currency is GBP · Price in SEK 118.30
-14.85 (-11.15%)
Feb 12, 2026, 4:21 PM GMT
Ambea AB Market Cap
Ambea AB has a market cap or net worth of 787.32 million as of February 12, 2026. Its market cap has increased by 38.02% in one year.
Market Cap
787.32M
Enterprise Value
1.82B
Revenue
1.31B
Ranking
n/a
PE Ratio
14.69
Stock Price
118.30
Market Cap Chart
Since March 31, 2017, Ambea AB's market cap has increased from 498.74M to 787.32M, an increase of 57.86%. That is a compound annual growth rate of 5.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 787.32M | -17.96% |
| Dec 30, 2025 | 959.65M | 63.83% |
| Dec 30, 2024 | 585.78M | 59.74% |
| Dec 29, 2023 | 366.71M | 10.68% |
| Dec 30, 2022 | 331.32M | -29.22% |
| Dec 30, 2021 | 468.09M | -15.17% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| HUTCHMED (China) | 1.88B |
| Oxford Nanopore Technologies | 1.40B |
| Oxford Biomedica | 998.08M |
| CVS Group | 977.97M |